BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 24, 2016
View Archived Issues
Mutations in ZAS may be associated with congenital myopathy
Read More
Mersana's XMT-1536 targets tumors expressing sodium-dependent phosphate transport protein 2B
Read More
TRIP-13 identified as a therapeutic target in hepatocellular carcinoma
Read More
Vasohibin-1 shows promise as a therapeutic target for diabetic erectile dysfunction
Read More
Ionis and MD Anderson form strategic alliance to discover and develop novel cancer therapeutics
Read More
Darzalex receives European conditional marketing authorization for multiple myeloma
Read More
Positive topline results from a first-in-human trial of broad spectrum MVA-BN RSV vaccine
Read More
Catabasis' SREBP inhibitors show potential for NASH
Read More
Merck & Co. patent orexin receptor antagonists
Read More
ETHZ, Roche and Universität Zürich disclose CB2 receptor ligands
Read More
ECUST and SIMM report dipeptidyl peptidase IV inhibitors
Read More
Enanta Pharmaceuticals discloses farnesoid X receptor agonists
Read More
IOmet Pharma divulges indoleamine and tryptophan dioxygenase inhibitors
Read More
Bayer Schering Pharma announces t-PA inhibitors
Read More
New studies support utility of GastroPanel to predict stomach cancer risk
Read More
Advanced Accelerator Applications scales up Lutathera production
Read More
Survival benefit with Pentaglobin in severe infections caused by multidrug-resistant bacteria
Read More
Onoclys BioPharma announces licensing developments
Read More
FDA awards fast track designation for AEB-1102 in hyperargininemia
Read More
Boehringer Ingelheim and Biomed X establish a global research team
Read More
Avastin approved in Japan for cervical cancer
Read More
Phase III trial results presented for alirocumab in Japan
Read More
Alimera reports real world data on Iluvien in patients with DME
Read More
Exelixis reports phase II results for cabozantinib
Read More
Interim phase II data for bardoxolone methyl show improvement in renal function
Read More
Arbor Pharmaceuticals set to acquire XenoPort
Read More
ZVex/mIL12 shows promising antitumor effect in vivo
Read More